Oncology Nutrition

Oncology Nutrition


Global Oncology Nutrition Market to Reach US$2.5 Billion by 2030

The global market for Oncology Nutrition estimated at US$1.4 Billion in the year 2023, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 9.4% over the analysis period 2023-2030. Head & Neck Cancer Nutrition, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$609.6 Million by the end of the analysis period. Growth in the Stomach & Gastrointestinal Cancer Nutrition segment is estimated at 11.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$481.3 Million While China is Forecast to Grow at 11.3% CAGR

The Oncology Nutrition market in the U.S. is estimated at US$481.3 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$254.5 Million by the year 2030 trailing a CAGR of 11.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.2% and 7.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.2% CAGR.

Global Oncology Nutrition Market - Key Trends & Drivers Summarized

What Is Oncology Nutrition and Why Is It Critical?
Oncology nutrition focuses on meeting the unique dietary needs of cancer patients to help manage symptoms and improve treatment outcomes. Nutrition plays a pivotal role in oncology because cancer and its treatments can significantly affect the patient`s ability to eat and absorb nutrients. Proper nutritional care can help maintain body strength, decrease infection risks, improve quality of life, and enhance recovery rates. It involves personalized diet plans that address specific nutritional deficiencies, manage treatment side effects like nausea and weight loss, and support the body’s immune system and overall health during and after treatment.

How Does Research Influence Oncology Nutrition Practices?
Continuous research in oncology nutrition has deepened understanding of how certain foods and nutrients affect tumor growth, patient resilience, and treatment response. Studies have identified specific nutritional strategies that can mitigate the side effects of cancer treatments, such as chemotherapy-induced nausea or radiation-induced weight loss. For instance, omega-3 fatty acids are found to help preserve muscle mass in cancer patients, while antioxidants in fruits and vegetables may reduce the oxidative stress caused by chemotherapy. This growing body of research supports the development of more effective, evidence-based nutritional guidelines and interventions for cancer care.

What Role Do Healthcare Professionals Play in Oncology Nutrition?
Healthcare professionals, including oncologists, dietitians, and nutrition specialists, play a crucial role in integrating nutrition into cancer care. They work collaboratively to assess the nutritional status of patients, devise customized nutrition plans, and adjust these plans as treatment progresses. Education provided by these professionals is vital, as it empowers patients and caregivers to make informed decisions about food choices and dietary habits during cancer treatment. Their expertise ensures that nutritional strategies are safely and effectively aligned with therapeutic goals, thereby optimizing patient outcomes and adherence to nutrition recommendations.

What Drives the Growth in the Oncology Nutrition Market?
The growth in the oncology nutrition market is driven by several factors, including rising global cancer incidence rates, growing awareness of the link between nutrition and cancer recovery, and advancements in nutritional research. As the global population ages, the number of cancer cases continues to climb, increasing the demand for specialized nutritional strategies to support oncology patients. Moreover, as patients and healthcare providers become more aware of how diet impacts treatment efficacy and patient quality of life, there is a greater emphasis on integrating tailored nutritional care into overall cancer treatment plans. Technological advancements in nutritional assessment tools and increased investment in nutrition-focused research further fuel market growth, enhancing the understanding and implementation of effective oncology nutrition practices.

Select Competitors (Total 31 Featured) -
  • Abbott Laboratories, Inc.
  • B. Braun Melsungen AG
  • Koninklijke DSM N.V.
  • Baxter International, Inc.
  • Fresenius Kabi AG
  • Fresenius SE & Co. KGaA
  • Aceto Corporation
  • Meiji Holdings Co., Ltd.
  • Nestle Health Science SA
  • Mead Johnson & Company, LLC.
  • Nutricia BV
  • Alniche Life Sciences Pvt., Ltd.
  • Global Health Products, Inc.
  • Pristine Organics Pvt. Ltd.
  • Hexagon Nutrition
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Oncology Nutrition - Global Key Competitors Percentage Market Share in 2024 (E)
Global Economic Update
Cancer - Food choices, Dietary habits and Cancer risk
Significance of Proper Nutrition for Cancer Patients
What to Eat in Cancer
Importance of Adequate Nutrition during Cancer Treatment
Nutrition During Cancer Treatment
Common Causes of Nutrition and Malnutrition in Cancer Patients
Cancer Treatment Side Effects that are Likely to Cause Dehydration and Malnutrition
Commercial Feeding Formulas
Factors to be Considered When Selecting a Particular Formula
Global Market Analysis and Prospects
Global Oncology Nutrition Market Witnesses Rapid Growth
Developed Regions Account for Major Share, Developing Regions Witness Rapid Growth
Competition
Recent Market Activity
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Global Incidence of Cancer Drives the Oncology Nutrition Market
Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
Rising Number of Malnourished Cancer Patients Drive the Demand for Oncology Nutrition Market
Patient Diagnosis with Malnutrition
Post Treatment Duration and Nutrition for Advanced Cancer
Meeting Nutritional Needs of Cancer Patients
Nutrition for Breast Cancer Survivorship
Introduction of Nutrient-Rich Oncology Nutritional Supplements Ensure Quick Recovery for Cancer Patients
Ongoing Research and Development Initiatives Fuel Demand for Oncology Nutrition Products
Demand for Gluten and Lactose-Free Enteral Nutrition Formulas Exhibits an Upward Momentum
Launch of New Nutritional Products for Cancer Patients
Diet for Colon Cancer Surgery
Ageing Demographics to Drive Market Demand
Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
Uptrend in Healthcare Spending Drives Market Demand
World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
Enteral Nutrition Market to Remain Buoyant and Strong
Oncology Applications Leads EN Market
Shift towards Home Care Boosts Demand for Clinical Nutrition Products
Changing Health and Social Care Factors Favor Home Enteral Feeding
Increasing Popularity of Intravenous Vitamin C for Cancer Treatment
Shift towards Enteral Nutrition Therapies - A Threat to Parenteral Nutrition Market
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Head & Neck by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Head & Neck by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Head & Neck by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Stomach & Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Stomach & Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Stomach & Gastrointestinal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Pancreatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Pancreatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Pancreatic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Breast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Breast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Breast by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Liver by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Other Cancer Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 23: World Historic Review for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 24: World 16-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 25: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 26: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 27: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 28: World Oncology Nutrition Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
TABLE 29: World Recent Past, Current & Future Analysis for Oncology Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 30: World Historic Review for Oncology Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 31: World 16-Year Perspective for Oncology Nutrition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 32: USA Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 33: USA Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 34: USA 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 35: USA Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: USA Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: USA 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
TABLE 38: Canada Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: Canada Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: Canada 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 41: Canada Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: Canada Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: Canada 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 44: Japan Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: Japan Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: Japan 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 47: Japan Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 48: Japan Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: Japan 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 50: China Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: China Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: China 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 53: China Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 54: China Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: China 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 56: Europe Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: Europe Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: Europe 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 59: Europe Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: Europe Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: Europe 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 62: Europe Recent Past, Current & Future Analysis for Oncology Nutrition by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 63: Europe Historic Review for Oncology Nutrition by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: Europe 16-Year Perspective for Oncology Nutrition by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
FRANCE
Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 65: France Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: France Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: France 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 68: France Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: France Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: France 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 71: Germany Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 72: Germany Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: Germany 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 74: Germany Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: Germany Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: Germany 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
TABLE 77: Italy Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: Italy Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: Italy 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 80: Italy Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: Italy Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: Italy 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 83: UK Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: UK Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: UK 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 86: UK Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: UK Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: UK 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
SPAIN
TABLE 89: Spain Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: Spain Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: Spain 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 92: Spain Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Spain Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Spain 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
RUSSIA
TABLE 95: Russia Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 96: Russia Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: Russia 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 98: Russia Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 99: Russia Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 100: Russia 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 102: Rest of Europe Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 103: Rest of Europe 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 105: Rest of Europe Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 106: Rest of Europe 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 108: Asia-Pacific Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 109: Asia-Pacific 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 111: Asia-Pacific Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 112: Asia-Pacific 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Oncology Nutrition by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 114: Asia-Pacific Historic Review for Oncology Nutrition by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 115: Asia-Pacific 16-Year Perspective for Oncology Nutrition by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
AUSTRALIA
Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 116: Australia Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 117: Australia Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 118: Australia 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 119: Australia Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 120: Australia Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 121: Australia 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
INDIA
Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 122: India Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 123: India Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 124: India 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 125: India Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 126: India Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 127: India 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 128: South Korea Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 129: South Korea Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 130: South Korea 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 131: South Korea Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 132: South Korea Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 133: South Korea 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 135: Rest of Asia-Pacific Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 138: Rest of Asia-Pacific Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
LATIN AMERICA
Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 140: Latin America Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 141: Latin America Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 142: Latin America 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 143: Latin America Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 144: Latin America Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 145: Latin America 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 146: Latin America Recent Past, Current & Future Analysis for Oncology Nutrition by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 147: Latin America Historic Review for Oncology Nutrition by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 148: Latin America 16-Year Perspective for Oncology Nutrition by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
ARGENTINA
TABLE 149: Argentina Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 150: Argentina Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 151: Argentina 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 152: Argentina Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 153: Argentina Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 154: Argentina 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
BRAZIL
TABLE 155: Brazil Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 156: Brazil Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 157: Brazil 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 158: Brazil Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 159: Brazil Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 160: Brazil 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
MEXICO
TABLE 161: Mexico Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 162: Mexico Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 163: Mexico 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 164: Mexico Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 165: Mexico Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 166: Mexico 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 168: Rest of Latin America Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 169: Rest of Latin America 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 171: Rest of Latin America Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 172: Rest of Latin America 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
MIDDLE EAST
Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 173: Middle East Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 174: Middle East Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 175: Middle East 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 176: Middle East Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 177: Middle East Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 178: Middle East 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 179: Middle East Recent Past, Current & Future Analysis for Oncology Nutrition by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 180: Middle East Historic Review for Oncology Nutrition by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 181: Middle East 16-Year Perspective for Oncology Nutrition by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
IRAN
TABLE 182: Iran Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 183: Iran Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 184: Iran 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 185: Iran Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 186: Iran Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 187: Iran 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
ISRAEL
TABLE 188: Israel Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 189: Israel Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 190: Israel 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 191: Israel Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 192: Israel Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 193: Israel 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 195: Saudi Arabia Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 196: Saudi Arabia 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 198: Saudi Arabia Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 199: Saudi Arabia 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 200: UAE Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 201: UAE Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 202: UAE 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 203: UAE Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 204: UAE Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 205: UAE 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 207: Rest of Middle East Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 208: Rest of Middle East 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 210: Rest of Middle East Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 211: Rest of Middle East 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
AFRICA
Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 212: Africa Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 213: Africa Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 214: Africa 16-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2014, 2024 & 2030
TABLE 215: Africa Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 216: Africa Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 217: Africa 16-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings